SARS-CoV-2 infection in multiple sclerosis patients: interaction with treatments, adjuvant therapies, and vaccines against COVID-19

The SARS-CoV-2 pandemic has raised particular concern for people with Multiple Sclerosis, as these people are believed to be at increased risk of infection, especially those being treated with disease-modifying therapies. Therefore, the objective of this review was to describe how COVID-19 affects p...

Descripción completa

Detalles Bibliográficos
Autores principales: Muñoz-Jurado, Ana, Escribano, Begoña M., Agüera, Eduardo, Caballero-Villarraso, Javier, Galván, Alberto, Túnez, Isaac
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253265/
https://www.ncbi.nlm.nih.gov/pubmed/35788744
http://dx.doi.org/10.1007/s00415-022-11237-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253265/
https://www.ncbi.nlm.nih.gov/pubmed/35788744
http://dx.doi.org/10.1007/s00415-022-11237-1

Ejemplares similares